Name File Type Size Last Modified
  Code Repository for upload 06/07/2022 09:18:AM

Project Citation: 

Maini, Luca, and Pammolli, Fabio. Data and Code for: Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market. Nashville, TN: American Economic Association [publisher], 2023. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2023-04-14. https://doi.org/10.3886/E160781V1

Project Description

Summary:  View help for Summary External reference pricing (ERP), the practice of benchmarking domestic drug prices to foreign prices, generates an incentive for firms to withhold products from low-income countries. Using a novel moment inequality approach, we estimate a structural model to measure how ERP policies affect access to innovative drugs across Europe. We find that ERP increases entry delays in eight low-income European countries by up to one year per drug. The European Union could remove these delays without replacing ERP by compensating firms through lump-sum transfers at the cost of around 18 million euros per drug.

Scope of Project

Subject Terms:  View help for Subject Terms prescription drugs; moment inequality; reference pricing
JEL Classification:  View help for JEL Classification
      I11 Analysis of Health Care Markets
      L65 Chemicals; Rubber; Drugs; Biotechnology; Plastics
Geographic Coverage:  View help for Geographic Coverage Europe
Time Period(s):  View help for Time Period(s) 2002 – 2012
Universe:  View help for Universe Prescription drugs sold in Europe from 2002 to 2012
Data Type(s):  View help for Data Type(s) aggregate data

Methodology

Data Source:  View help for Data Source IMS MIDAS
Unit(s) of Observation:  View help for Unit(s) of Observation Drug, Country, Year

Related Publications

Published Versions

Export Metadata

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.